Skip to main content

and
  1. No Access

    Article

    Quality-of-life assessment in patients with bladder cancer

    Surgical treatments for bladder cancer are associated with long-term morbidities that affect bladder and sexual function. This Review on health-related quality of life (HRQOL) examines the important issues sur...

    Jonathan L Wright, Michael P Porter in Nature Clinical Practice Urology (2007)

  2. Article

    Open Access

    Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study

    Metformin is a commonly used medication for type II diabetes mellitus. Epidemiologic studies have suggested a decreased relative risk of cancer with metformin use, and preclinical studies of prostate cancer (P...

    Jonathan L. Wright, Janet L. Stanford in Cancer Causes & Control (2009)

  3. No Access

    Article

    Prostate cancer risk stratification by genotype and PSA

    The use of PSA testing as a screening tool for prostate cancer is limited by its low specificity. New data offer insight into how genotypic information might be incorporated into PSA screening approaches to en...

    Jonathan L. Wright, Daniel W. Lin in Nature Reviews Urology (2009)

  4. No Access

    Article

    Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study

    Hospital cystectomy volume has been associated with in-hospital perioperative mortality in previous studies. In this study, we examine the relationship between hospital cystectomy volume and 90-day mortality i...

    Michael P. Porter, John L. Gore, Jonathan L. Wright in World Journal of Urology (2011)

  5. No Access

    Article

    Coffee and tea consumption in relation to prostate cancer prognosis

    Bioactive compounds found in coffee and tea may delay the progression of prostate cancer.

    Milan S. Geybels, Marian L. Neuhouser, Jonathan L. Wright in Cancer Causes & Control (2013)

  6. Article

    Open Access

    Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy

    Identifying the subset of patients with clinically localized prostate cancer (PCa) at the highest risk of recurrence remains challenging, and better prognostic markers are needed. Gleason score is the best pre...

    Milan S. Geybels, Jonathan L. Wright, Marina Bibikova in Clinical Epigenetics (2016)

  7. Article

    Open Access

    Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis

    Muscle-invasive bladder cancer (MIBC) is a heterogeneous disease, and gene expression profiling has identified several molecular subtypes with distinct biological and clinicopathological characteristics. While...

    Joep J. de Jong, Yang Liu, A. Gordon Robertson, Roland Seiler in Genome Medicine (2019)

  8. No Access

    Article

    The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study

    The prostate biopsy pathology report represents a critical document used for decision-making in patients diagnosed with prostate cancer, yet the content exceeds the health literacy of most patients. We sought ...

    Jasmir G. Nayak, Nicholas Scalzo, Alice Chu in Prostate Cancer and Prostatic Diseases (2020)

  9. No Access

    Article

    Copy number alterations are associated with metastatic-lethal progression in prostate cancer

    Aside from Gleason score few factors accurately identify the subset of prostate cancer (PCa) patients at high risk for metastatic progression. We hypothesized that copy number alterations (CNAs), assessed usin...

    **aoyu Wang, Catherine S. Grasso in Prostate Cancer and Prostatic Diseases (2020)

  10. Article

    Open Access

    A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture

    Bladder cancer is among the most prevalent cancers worldwide. Currently, few bladder cancer models have undergone thorough characterization to assess their fidelity to patient tumors, especially upon propagati...

    Elise Y. Cai, Jose Garcia, Yuzhen Liu, Funda Vakar-Lopez in Scientific Reports (2021)

  11. Article

    Open Access

    Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer

    To assess the association of patient age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (MIBC).

    David D’Andrea, Peter C. Black, Homayoun Zargar in World Journal of Urology (2021)

  12. No Access

    Article

    Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer

    Cisplatin-based chemotherapy followed by radical cystectomy (RC) is recommended in patients with muscle-invasive bladder cancer (MIBC). However, up to 50% of patients are cisplatin ineligible. The aim of this ...

    Sarah M. H. Einerhand, Anna J. Black, Homayoun Zargar in World Journal of Urology (2022)

  13. Article

    Open Access

    A combinatorial genetic strategy for exploring complex genotype–phenotype associations in cancer

    Available genetically defined cancer models are limited in genotypic and phenotypic complexity and underrepresent the heterogeneity of human cancer. Here, we describe a combinatorial genetic strategy applied t...

    Shan Li, Alicia Wong, Huiyun Sun, Vipul Bhatia, Gerardo Javier in Nature Genetics (2024)